Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder

Conclusions
These findings suggest that the MRS is a potential genetic marker in understanding SZ, particularly in patients with a genetic SZ risk.

Source: Evidence-Based Mental Health - January 11, 2024 Category: Psychiatry & Psychology Authors: Ohi, K., Shimada, M., Soda, M., Nishizawa, D., Fujikane, D., Takai, K., Kuramitsu, A., Muto, Y., Sugiyama, S., Hasegawa, J., Kitaichi, K., Ikeda, K., Shioiri, T. Tags: Open access Genetics and genomics Source Type: research